Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about CYBN

Recent news which mentions CYBN

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Cybin Inc. Begins Phase 3 Trials, Betting Big On CYB003 To Treat Depression
Tickers CYBN
Tags major depressive disorder Psychedelics neuropsychiatric treatment
From Benzinga
EXCLUSIVE: Neuropsychiatry-Focused Cybin Secures First US Composition of Matter Patent For Preclinical CYB005 Phenethylamines Program
Tickers CYBN NEWS
Tags Health Care Market News Benzinga
From Benzinga
Leadership Shake-Ups In Cannabis And Psychedelics: Maryland's Cannabis Chief Resigns, Costly Legal Battle In MA Drags On & More
Tickers AAWH CCC CYBN NEWS
Tags Cannabis executives Psychedelics CCC
From Benzinga
CYBN Stock Earnings: Cybin Beats EPS for Q1 2024
Tickers CYBN
Tags CYBN NYSE:CYBN Earnings Reports
From InvestorPlace
EXCLUSIVE: Legal Magic Mushroom Products Will Be Sold In Jamaica As Psilocybin Products Hit Pharmacy Shelves
Tickers ATAI CMPS CYBN HAVLF
Tags HAVLF ATAI MNMD
From Benzinga
3 Biotech Stocks That Could Make Your Summer Unforgettable
Tickers CYBN GPCR JEF LLY
Tags LLY Market News GPCR
From InvestorPlace
Psychedelic Picks: 3 Trippy Stocks Aiming for Out-of-This-World Returns
Tickers ATAI CYBN GHRS
Tags GHRS CYBN ATAI
From InvestorPlace
3 Psychedelic Stocks to Buy on the Dip: Summer 2024
Tickers ATAI CMPS CYBN
Tags Stocks to Buy NASDAQ:ATAI,NASDAQ:CMPS,NYSEMKT:CYBN Market News
From InvestorPlace
CYBN Stock Earnings: Cybin Beats EPS for Q4 2023
Tickers CYBN
Tags Earnings Reports NYSEMKT:CYBN CYBN
From InvestorPlace
Biopharma Co. Cybin Reports $78M Loss Amid Accelerating Expansion In Psychedelic Therapies, Drug Development
Tickers CYBN
Tags Cannabis Earnings Market News
From Benzinga
Latest Executive Cannabis Changes You Should Know About: Curaleaf, Planet 13 Elect Directors And More
Tickers CURA CURLF CWBHF CWEB
Tags New Jersey Cannabis CWBHF TLLTF
From Benzinga
Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment
Tickers ATAI CYBN MDMA MNMD
Tags Top Stories Stories That Matter MDMA
From Benzinga
Pot Company Gets License To Open Psilocybin Service Center, The Sacred Mushroom, In Oregon
Tickers ATAI CMPS CYBN KAYS
Tags CMPS CYBN ATAI
From Benzinga
Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More
Tickers CMND CMPS CYBN FLHLF
Tags Psychedelics CMND MDXXF
From Benzinga
3 Penny Stocks That Could Be Multibaggers in the Making: March Edition
Tickers CLNN CYBN LIFE
Tags CYBN NASDAQ:CLNN,NASDAQ:LIFE,NYSEAMERICAN:CYBN Stocks to Buy
From InvestorPlace
Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
Tickers ATAI CMND CMPS CYBN
Tags LSDI TRUFF PBM
From Benzinga
FDA Grants Cybin Breakthrough Therapy Status For Major Depression Psilocybin Therapy, Company Announces Positive Clinical Data & Canadian $150M Private Placement
Tickers CMPS CYBN MNMD
Tags CMPS CYBN MNMD
From Benzinga
3 High-Potential Penny Stocks to Turn $1000 into $1 million
Tickers CYBN GOEV JOB
Tags NASDAQ:GOEV,NYSEMKT:CYBN,NYSEMKT:JOB Market News Uncategorized
From InvestorPlace
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
Tickers ATAI CMND CMPS CYBN
Tags CMND Psychedelics DRUG
From Benzinga
Cybin Inc. Q3 Earnings: Clinical Advances Amid Financial Loss
Tickers CYBN NEWS
Tags Biotech Psychedelics Cannabis
From Benzinga
Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More
Tickers ATAI AWKNF CMND CYBN
Tags CYBN Management Psychedelics Reform
From Benzinga
Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More
Tickers ATAI CMND CMPS CYBN
Tags ATAI MNMD Legal
From Benzinga
FDA Green Lights Cybin's Psychedelic Clinical Study Assessing Generalized Anxiety
Tickers CYBN NEWS
Tags Psychedelics Clinical Studies Markets CYBN
From Benzinga
Psychedelics Headlines: MDMA & Coping Skills In PTSD, LSD's Perceived Risks, Knowledge Gaps, Surveys & More
Tickers ATAI CMND CMPS CYBN
Tags TSLA Psychedelics CMND
From Benzinga
Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More
Tickers ATAI CMND CMPS CYBN
Tags ATAI MNMD IXHL
From Benzinga
30 Psychedelics Executives, Scientists & Influencers To Watch In 2024 And Beyond
Tickers CYBN ENVB NEWS NUMIF
Tags ENVB Markets TRIL
From Benzinga
Cybin Inc's Two Deuterated Psychedelic Molecules Achieve Positive Topline Clinical Results
Tickers CYBN NEWS
Tags Deuterated Psychedelics Markets CYBN
From Benzinga
Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD
Tickers ATAI CMPS CYBN DMTTF
Tags CMPS CYBN Government
From Benzinga
Psychedelic Stock Gainers And Losers From January 1, 2024
Tickers ATAI CMPS CYBN GHRS
Tags CYBN CMPS MNMD
From Benzinga
Mind-Bending Growth: 3 Psychedelic Stocks With Trippy Potential
Tickers BIIB CYBN SUPN
Tags BIIB NYSE:CYBN,NASDAQ:SUPN,NASDAQ:BIIB CYBN
From InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.